Back to Journals » OncoTargets and Therapy » Volume 14

LHX6 Affects Erlotinib Resistance and Migration of EGFR-Mutant Non-Small-Cell Lung Cancer HCC827 Cells Through Suppressing Wnt/β-Catenin Signaling [Corrigendum]

Authors Wang Q, Liao J, He Z, Su Y, Lin D, Xu L, Xu H, Lin J

Received 31 December 2020

Accepted for publication 31 December 2020

Published 12 January 2021 Volume 2021:14 Pages 253—254

DOI https://doi.org/10.2147/OTT.S299935

Download Article [PDF] 

Wang Q, Liao J, He Z, et al. Onco Targets Ther.  2020;13:10983– 10994


On page 10993, Funding section, “This study was supported by grants from the Natural Science Foundation of Fujian Province (grant nos. 2017J01261 and 2016JD1488)” should have been “This study was supported by grants from the Natural Science Foundation of Fujian Province (grant nos.  2017J01261 and 2016J01488)”.


The authors apologize for this error.

Read the original article

Further corrigendum has been published 

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]